What they found: Oral AOD-9604 reduced body fat by 18 to 22 % vs placebo, comparable to injection administration No changes in total body weight (because lean mass rose slightly) Decrease in plasma triglycerides by 30 % Decrease in resting free fatty acids (paradoxically, mobilization of fat from depots into oxidation) No GI side effects Why it matters: It suggested that AOD-9604 could work orally , a rare property for a peptide
We well as boost energy levels, improve symptoms of depression, anxiety, and mental clarity/ cognitive function
The N-acetyl variant is studied as a structurally stabilized tool compound for such investigations into cellular senescence, geroprotection, and peptide-receptor interactions
NewBioRx provides batch-specific Certificates of Analysis to support reproducibility and consistency in laboratory research applications
BPC-157 has been shown to influence the synthesis, release, and receptor sensitivity of various neurotransmitters, including serotonin and dopamine
Pattern separation and pattern completion in Alzheimers disease: evidence of rapid forgetting in amnestic mild cognitive impairment